Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934356 · ClinicalTrials.gov registry record · NA
Subcortical Arousal in Perceptual Awareness
A NA study of Epilepsy, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 8
- Study locations
NCT06934356: Recruiting NA study of Epilepsy, sponsored by Yale University.
NCT06934356 is a NA study of Epilepsy that is actively recruiting participants, run by Yale University. The registered enrollment target is 72 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (92% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934356, a NA study of Epilepsy, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 8
- Study locations
Study Summary
The study is a multi-site study and will be conducted at up to 11 investigative sites in the United States. The study will investigate subcortical arousal circuits in visual perception using techniques with complementary strengths based on promising initial studies.
Primary Outcome
Subcortical event-related signals will be recorded by icEEG to assess electrical activity from the cerebral cortex using currently implanted electrodes during the behavioral task
Conditions Studied
Interventions
- DEVICE EEG
- DEVICE Eye Tracking
- DEVICE Behavioral task
Study Locations (8)
Connecticut
- Yale School of Medicine - New Haven
Kansas
- University of Kansas Medical Center - Kansas City
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-10-13 |
| Est. Completion | 2030-12 |
| Phase | NA |
What NCT06934356 shows while recruiting
NCT06934356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 3 interventions - of which EEG is the first listed.
NCT06934356 lists 8 locations in 8 states (Connecticut, Kansas, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06934356 about?
NCT06934356 is a clinical study titled "Subcortical Arousal in Perceptual Awareness". The study is a multi-site study and will be conducted at up to 11 investigative sites in the United States. The study will investigate subcortical arousal circuits in visual perception using techniques with complementary strengths based on promising initial studies.
What is the current status of trial NCT06934356?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-10-13. Estimated completion is 2030-12.
What conditions does trial NCT06934356 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT06934356?
The interventions under investigation include: EEG (DEVICE), Eye Tracking (DEVICE), Behavioral task (DEVICE).
Who is sponsoring clinical trial NCT06934356?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934356 being conducted?
This trial has 8 study locations across Connecticut, Kansas, Massachusetts, Minnesota, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06934356's enrollment target sits among peer trials
72 71st of 160 higher than 89 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI